The OBJ active patch technology is the new generation of active drug delivery.

It combines the abilities of iontophoresis to mobilize drug molecules with electroporation’s ability to control the behavior of the dermal barrier effect. However it controls both of these independently and does so in a totally reversible, minimally invasive manner.

It is ideally suitable for the over-the-counter and self-administration market, and can dramatically reduce the time to onset and delivery of a wide range of pharmaceutical products.

In independent University studies, the OBJ active patch technology was shown to provide a wide range of delivery capabilities across an equally wide range of commercial drugs.

The drugs outlined in this overview are indicative rather than specific and were selected for their difficulty in passive transdermal delivery.

Click each drug to view details of transdermal drug studies:

5-aminolevulinic acid (5-ALA)

Hydrocortisone

Naltrexone Hydrochloride

Caffeine

Vaccines